We are live on
!
Find out more
Wealthfront Advisers Portfolio holdings
AUM
$52B
Turnover
7.12%
1-Year Est. Return
24.53%
This Fund
S&P 500
This Quarter
Est. Return
-6.81%
1 Year Est. Return
+24.53%
3 Year Est. Return
+63.26%
5 Year Est. Return
+56.07%
10 Year Est. Return
–
AUM
$18.8B
AUM Growth
-$1.09B
(-5.5%)
Cap. Flow
+$370M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
69.6%
Holding
796
New
33
Increased
414
Reduced
312
Closed
37
Avg Time Held
2.4
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$270M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$218M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$176M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$164M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$65.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$249M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$210M |
| 3 |
Schwab International Equity ETF
SCHF
|
+$69M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$55.4M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$44.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 84.79% |
| 2 | Technology | 3.22% |
| 3 | Healthcare | 2.29% |
| 4 | Financials | 1.89% |
| 5 | Consumer Discretionary | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
Royalty Pharma
RPRX
$27.3B
| $392K | ﹤0.01% |
9,754
+2,580
| +36% | +$110K |
2022 Q2
1 quarter
|
|
652
Vanguard Total World Stock ETF
VT
$81.2B
| $386K | ﹤0.01% |
4,892
+1,716
| +54% | +$151K |
2021 Q4
3 quarters
|
|
653
Northern Trust
NTRS
$30.3B
| $385K | ﹤0.01% |
4,505
-534
| -11% | -$51.6K |
2020 Q2
9 quarters
|
|
654
Ball Corp
BALL
$16.7B
| $382K | ﹤0.01% |
7,907
-3,188
| -29% | -$196K |
2018 Q4
15 quarters
|
|
655
Flowserve
FLS
$8.99B
| $380K | ﹤0.01% |
15,654
-3,708
| -19% | -$112K |
2019 Q4
11 quarters
|
|
656
Global X SuperDividend ETF
SDIV
$1.16B
| $371K | ﹤0.01% |
16,400
+3,701
| +29% | +$98.9K |
2022 Q1
2 quarters
|
|
657
Live Nation Entertainment
LYV
$39.7B
| $367K | ﹤0.01% |
4,821
+550
| +13% | +$49.3K |
2020 Q4
7 quarters
|
|
658
Zebra Technologies
ZBRA
$17.5B
| $367K | ﹤0.01% |
1,402
-410
| -23% | -$127K |
2019 Q2
13 quarters
|
|
659
Invesco S&P 500 Low Volatility ETF
SPLV
$7.26B
| $366K | ﹤0.01% |
6,325
+2,172
| +52% | +$137K |
2022 Q2
1 quarter
|
|
660
Charles River Laboratories
CRL
$14.3B
| $364K | ﹤0.01% |
1,849
+464
| +34% | +$100K |
2021 Q1
6 quarters
|
|
661
iShares US Treasury Bond ETF
GOVT
$42.1B
| $363K | ﹤0.01% |
15,961
+6,731
| +73% | +$159K |
2021 Q4
3 quarters
|
|
662
Northern Trust International Quality Dividend ETF
IQDF
$1.12B
| $360K | ﹤0.01% |
20,229
+192
| +1% | +$3.85K |
2022 Q1
2 quarters
|
|
663
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.9B
| $359K | ﹤0.01% |
2,107
+320
| +18% | +$60.6K |
2021 Q4
3 quarters
|
|
664
Vanguard Materials ETF
VAW
$3.22B
| $351K | ﹤0.01% |
2,365
-1,974
| -45% | -$326K |
2021 Q2
5 quarters
|
|
665
iShares MSCI ACWI ETF
ACWI
$32.6B
| $346K | ﹤0.01% |
4,442
+1,229
| +38% | +$106K |
2022 Q2
1 quarter
|
|
666
Robert Half
RHI
$3.4B
| $346K | ﹤0.01% |
4,517
-132
| -3% | -$10.3K |
2020 Q2
9 quarters
|
|
667
Global X MLP ETF
MLPA
$2.28B
| $345K | ﹤0.01% |
8,747
+821
| +10% | +$33.2K |
2022 Q1
2 quarters
|
|
668
KraneShares Global Carbon Strategy ETF
KRBN
$137M
| $344K | ﹤0.01% |
9,236
+2,155
| +30% | +$95.2K |
2022 Q2
1 quarter
|
|
669
Vanguard Consumer Discretionary ETF
VCR
$5.78B
| $341K | ﹤0.01% |
1,449
-755
| -34% | -$195K |
2021 Q3
4 quarters
|
|
670
Invitation Homes
INVH
$16B
| $336K | ﹤0.01% |
9,936
-2,173
| -18% | -$80.5K |
2022 Q1
2 quarters
|
|
671
iShares California Muni Bond ETF
CMF
$4.97B
| $335K | ﹤0.01% |
6,181
+2,253
| +57% | +$128K |
2022 Q2
1 quarter
|
|
672
Match Group
MTCH
$9.81B
| $335K | ﹤0.01% |
7,018
-1,344
| -16% | -$84.4K |
2021 Q4
3 quarters
|
|
673
iShares Russell Mid-Cap Value ETF
IWS
$15.4B
| $333K | ﹤0.01% |
3,470
+1,166
| +51% | +$125K |
2022 Q2
1 quarter
|
|
674
Lear
LEA
$5.93B
| $329K | ﹤0.01% |
2,750
-13,062
| -83% | -$1.81M |
2021 Q4
3 quarters
|
|
675
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$326M
| $329K | ﹤0.01% |
4,514
+1,152
| +34% | +$92.2K |
2022 Q1
2 quarters
|
|
Similar funds
Wealthfront Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Wealthfront Advisers held 796 positions worth $18.8B, down 5.5% from $19.9B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Wealthfront Advisers's Q3 2022 filing shows 33 new, 414 increased, 312 reduced and 37 closed positions. Its largest new stake was Fidelity National Financial: 101,993 shares worth $3.55M. The largest sale was State Street SPDR Nuveen ICE Municipal Bond ETF, an estimated $249M.
By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, down from 85% a quarter earlier, followed by Technology and Healthcare.
- Wealthfront Advisers's largest Q3 2022 buy was Fidelity National Financial: 101,993 shares worth $3.55M.
- Wealthfront Advisers added most to Vanguard Tax-Exempt Bond Index Fund in Q3 2022, an estimated $270M increase.
- Wealthfront Advisers's biggest Q3 2022 reduction was State Street SPDR Nuveen ICE Municipal Bond ETF, cutting an estimated $249M.
- Wealthfront Advisers fully exited Teladoc Health in Q3 2022, selling an estimated $2.7M.
- Wealthfront Advisers's ten largest holdings make up 70% of its $18.8B portfolio in Q3 2022.
- Wealthfront Advisers opened 33 new positions and closed 37 in Q3 2022.
- Wealthfront Advisers's portfolio value fell 5.5% quarter-over-quarter to $18.8B.
Based on Wealthfront Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.